About Curoverse
Curoverse is a company based in Boston (United States) founded in 2010 was acquired by Veritas Genetics in August 2017.. Curoverse has raised $1.7 million across 3 funding rounds from investors including Veritas Genetics, HHS and Hatteras Venture Partners. Curoverse offers products and services including Arvados. Curoverse operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
- Headquarter Boston, United States
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gorillaspace Pte. Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.7 M (USD)
in 3 rounds
-
Latest Funding Round
$500 K (USD), Debt – Conventional
Mar 24, 2015
-
Investors
Veritas Genetics
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Veritas Genetics
(Aug 03, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curoverse
Curoverse offers a comprehensive portfolio of products and services, including Arvados. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for managing and processing large biomedical data sets securely.
Funding Insights of Curoverse
Curoverse has successfully raised a total of $1.7M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $500 thousand completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $500,000
-
First Round
First Round
(18 Feb 2014)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Debt – Conventional - Curoverse | Valuation |
investors |
|
| Sep, 2014 | Amount | Grant - Curoverse | Valuation |
investors |
|
| Feb, 2014 | Amount | Seed - Curoverse | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Curoverse
Curoverse has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Veritas Genetics, HHS and Hatteras Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location | |
|
Tech focused early stage VC firm investing in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Curoverse
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Curoverse
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Curoverse Comparisons
Competitors of Curoverse
Curoverse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Curoverse
When was Curoverse founded?
Curoverse was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Where is Curoverse located?
Curoverse is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Curoverse a funded company?
Curoverse is a funded company, having raised a total of $1.7M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.7M, raised on Feb 18, 2014.
What does Curoverse do?
Curoverse was founded in 2010 in Boston, United States, within the genomic and biomedical sector. Open source software is utilized entirely in its platform. Arvados, a free and open source system originally developed for the Harvard Personal Genome Project, forms its core. Data management, computation, and sharing needs specific to genomic and biomedical data are handled through this infrastructure, supporting research operations across the field.
Who are the top competitors of Curoverse?
Curoverse's top competitors include Helix, Benchling and BioAge Labs.
What products or services does Curoverse offer?
Curoverse offers Arvados.
Who are Curoverse's investors?
Curoverse has 7 investors. Key investors include Veritas Genetics, HHS, Hatteras Venture Partners, MassVentures, and Boston Global Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.